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Abstract
Background: DNA methylation is an important epigenetic control mechanism that has been shown to be
associated with gene silencing through the course of development, maturation and aging. However, only limited
data are available regarding the relationship between methylation and gene expression in human development.
Results: We analyzed the methylome and transcriptome of three human fetal liver samples (gestational age 20–22
weeks) and three adult human liver samples. Genes whose expression differed between fetal and adult numbered
7,673. Adult overexpression was associated with metabolic pathways and, in particular, cytochrome P450 enzymes
while fetal overexpression reflected enrichment for DNA replication and repair. Analysis for DNA methylation using the
Illumina Infinium 450 K HumanMethylation BeadChip showed that 42 % of the quality filtered 426,154 methylation sites
differed significantly between adult and fetal tissue (q≤ 0.05). Differences were small; 69 % of the significant sites
differed in their mean methylation beta value by ≤0.2. There was a trend among all sites toward higher methylation in
the adult samples with the most frequent difference in beta being 0.1. Characterization of the relationship between
methylation and expression revealed a clear difference between fetus and adult. Methylation of genes overexpressed
in fetal liver showed the same pattern as seen for genes that were similarly expressed in fetal and adult liver. In
contrast, adult overexpressed genes showed fetal hypermethylation that differed from the similarly expressed genes.
An examination of gene region-specific methylation showed that sites proximal to the transcription start site or within
the first exon with a significant fetal-adult difference in beta (>0.2) showed an inverse relationship with gene
expression.
Conclusions: Nearly half of the CpGs in human liver show a significant difference in methylation comparing fetal and
adult samples. Sites proximal to the transcription start site or within the first exon that show a transition from
hypermethylation in the fetus to hypomethylation or intermediate methylation in the adult are associated with inverse
changes in gene expression. In contrast, increases in methylation going from fetal to adult are not associated with
fetal-to-adult decreased expression. These findings indicate fundamentally different roles for and/or regulation of DNA
methylation in human fetal and adult liver.
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Background
Epigenetic regulation of gene expression allows for the
transmission of heritable traits and environmental effects
on phenotype in a manner independent of the DNA
sequence [1]. DNA methylation has been identified as
an important epigenetic control mechanism, particularly
in large-scale gene silencing, such as X-inactivation [2],
genomic imprinting [3], and silencing of transposable
elements in plants [4, 5]. Gene silencing associated with
DNA methylation has been found to occur through the
course of development, maturation and aging [6, 7].
DNA methylation, most often involving the addition
of a methyl group to a cytosine in the context of a CpG
site, can occur actively or passively. Passive demethyla-
tion is the loss of methylation marks during DNA
replication [8], whereas active demethylation is the
specific removal of methylation marks. Genome-wide
demethylation, an event thought to occur during early
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development, is followed by remethylation of imprinted
genes and genes encoded on the X-chromosome. DNA
methylation that is essential for embryonic cell differenti-
ation is erased during fertilization. Gene silencing methy-
lation then progressively accumulates as stem cells
irreversibly differentiate into various cell types [9]. Gene-
specific demethylation can also occur in response to envir-
onmental stress [8, 10] or in association with gene upregu-
lation as a mechanism of drug resistance [11].
DNA methylation occurs throughout the genome in
complex patterns and in varying gene regions, including
promoter regions. In general, DNA methylation of pro-
moter regions is correlated with reduced expression.
However, some methylation patterns within the gene
body are paradoxically associated with increased gene
expression [12, 13].
While there is an established role for DNA methylation
in the epigenetic regulation of gene expression, only limited
data have been published regarding this relationship in
human development. Our laboratory has a long-standing
interest in the regulation of fetal liver development and
programming of liver metabolism [14–18]. Elucidating the
mechanisms involved in the developmental programming
of hepatocyte growth, differentiation and metabolism is
critical to understanding the fetal origins of Type 2 diabetes
and metabolic syndrome [19, 20]. In this study, we compare
DNA methylation and gene expression from liver tissue of
human fetal and adult donors to examine the regulatory
role of this epigenetic mechanism in the context of normal
liver developmental physiology. We used the Illumina Infi-
nium 450 K HumanMethylation BeadChip to assess methy-
lation rates at over 480,000 CpG locations across the
human genome, and the Affymetrix Human Gene ST 1.0
array to measure gene expression for 33,297 genes. Our
findings point to complex and differing functional regula-
tion of gene expression by DNA methylation in mid-
gestation fetal and adult humans.
Results
Characterization of the fetal and adult liver transcriptome
and DNA methylome
We analyzed triplicate human fetal and adult liver
samples. All six samples were derived from males to
avoid differences related to sex-associated imprinting.
To minimize the variance due to developmental stage or
age, we selected samples from a narrow window: spon-
taneous fetal losses that occurred between 20 and
22 weeks gestation, and normal adult liver from individ-
uals who were 55 to 62 year olds. Histological analysis of
the fetal liver using hematoxylin and eosin-stained sec-
tions showed normal architecture with no evidence of
tissue injury or necrosis.
To characterize the pattern of differential gene expres-
sion in the fetal and adult liver samples, we used Gene Set
Enrichment Analysis (GSEA; Fig. 1a) [21]. A number of
gene sets, including Ribosome, DNA Replication, Systemic
Lupus Erythematosus, Cell Cycle, and Mismatch Repair,
were enriched in fetal liver. Enrichment of these gene sets
reflected changes in the expression of cell cycle constitu-
ents, histones, DNA replication factors and genes involved
in RNA processing. Conversely, many of the gene sets
enriched in adult liver reflected greater functional differ-
entiation. Among these were several gene sets that were
accounted for by higher expression of cytochrome P450
enzymes, transporters and complement factors. A number
of other gene sets enriched in adult liver were accounted
for by genes encoding enzymes involved in lipid and
amino acid metabolism.
We identified 7,673 genes whose expression level dif-
fered significantly between the fetal and adult liver sam-
ples (False Discovery Rate [FDR] q-value ≤0.05). We based
a priori gene selection for Ingenuity Pathway Analysis
(IPA®) on a significant difference in mean expression be-
tween the two groups of 5-fold. This resulted in 594 input
genes. Of these genes, 384 were overexpressed in fetal
liver and 210 were overexpressed in adult liver. IPA results
(Fig. 1b) were largely accounted for by higher expression
of genes associated with DNA replication in fetal liver and
cytochrome P450 enzymes in adult liver.
DNA methylation array analysis yielded 426,154 methy-
lation locations along the human genome that passed
quality filtering. We found that 179,284 of these sites
(42 %) differed significantly between adult and fetal tissue
(q ≤ 0.05). Despite statistically significant differences, we
found that the majority of these CpG sites did not differ
greatly in their overall level of methylation; 69 % of the
statistically significant sites (124,392) showed a difference
in their mean methylation beta value (delta beta; dβ) of
less than 0.2. Only 5 % of the statistically significant sites
(8,151) showed a mean dβ greater than 0.5.
The consistency of methylation within groups was
high. The mean variance for all fetal methylation sites
was 0.0011; the mean variance for the adult samples was
0.0017. Of all CpGs in both groups, 96 % had a variance
<0.01. Thus, the variance within groups was much less
than the change in methylation between groups despite
the fact that mean differences were generally small.
Of the sites that differed significantly between fetal
and adult, but for which dβ was ≤0.2, 72 % of sites
showed higher methylation in the adult samples. The
significantly different sites (30,495) with dβ >0.2 were
also more likely to be hypermethylated in the adult sam-
ples (56 %). Of the markedly undermethylated CpGs
(beta <0.3), most of the fetal CpGs (74 %) had a mean
dβ <0.05 in contrast to only 36 % of the corresponding
adult CpGs. Graphic representation (Fig. 2a) showed
that the differences between fetus and adult across the
full methylation range were subtle. The dβ distribution
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(Fig. 2b) showed a slight shift toward higher methylation
in the adult samples with the most frequent delta beta
approximating 0.01.
Distribution of DNA methylation within gene regions
The gene region in which DNA methylation occurs con-
tributes to the complexity of its effects on transcription
Fig. 1 Analysis of gene expression in fetal and adult liver. Microarray data were analyzed by GSEA (a) and IPA (b). Blue bars and red bars reflect
higher expression in the fetal and adult samples, respectively. Results are stratified based on level of significance. GSEA data are shown as the
FDR q-value. IPA results show the unadjusted p-value. The threshold for significance of the IPA results was determined using fetal (blue arrow)
and adult (red arrow) control data sets, as described in Methods
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[22]. We looked at two annotation sets to classify methyla-
tion effect by gene region, regulatory feature group (in-
cluding “promoter associated”) and reference gene group
(including “upstream of transcription start site”). Unfortu-
nately, 79 % of the CpGs did not have regulatory feature
group annotations, whereas 75 % of the CpGs did have
the reference gene group. A preliminary analysis of the
8,151 statistically different sites showing a dβ > 0.5 de-
scribed above, show that only 14 % had a regulatory fea-
ture group annotation, of which 92 % (1,049) were
specifically “promoter associated”. These promoter-
associated sites fell on 508 genes, more than 80 % of
which (416) did not show a significant change in expres-
sion (q ≤ 0.05, fold change > 2). Given the low levels of an-
notation for regulatory feature group, and the ambiguous
findings they provided, we chose instead to use the refer-
ence gene group annotations.
We characterized CpG methylation reference gene
groups into two distinct regions. Sites within 200 or
1,500 base pairs of the transcription start site (TSS200
and TSS1500, respectively) or within the first exon were
aggregated and designated as TSS/Ex1. The remaining
regions, 5’UTR, 3’UTR and gene body, were aggregated
and designated as UTR/GB [23, 24]. This approach to
combining sites was based on the observation that DNA
methylation of the promoter regions upstream of the
transcription start site has been linked to reduced ex-
pression while the methylation along the gene body can
have the converse effect [22, 13]. In addition, Brenet
et al. [25] describe the 1st exon as being tightly linked to
transcription. The appropriateness of this approach was
indeed confirmed by subsequent analyses (vide infra).
Using this approach, we found that the TSS/Ex sites
were much more likely to be hypomethylated than
hypermethylated (Fig. 3). This was in contrast to the
UTR/GB sites, which showed similar proportions of
hypo- and hypermethylation. This pattern of site-related
methylation was similar between the fetal and adult
samples.
We went on to examine the relationship between site of
methylation and gene expression. To do so, we created a
hierarchy for selection of methylation sites. We found lit-
tle if any relationship between methylation and gene
expression when all statisticallt significant methylation
events were included in the analysis (Fig. 4a). Additional
filtering based on dβ >0.2 (Fig. 4b) had little effect. The
same was true when we limited our analysis to TSS/
Ex1sites (Fig. 4c). However, combined filtering for dβ >0.2
and TSS/Ex1 location showed a strong relationship
(Fig. 4d). Genes for which TSS/Ex1 methylation was high
in the fetus were relatively overexpressed in adult liver.
Conversely, genes with high TSS/Ex1 methylation in adult
liver were relatively overexpressed in fetal liver. Low and
intermediate levels of TSS/Ex1 methylation did not appear
to be correlated with relative expression levels in fetal
liver. Low methylation in adult liver was associated with
relatively higher expression in adult liver, though this rela-
tionship was not as apparent as was the case for hyper-
methylated TSS/Ex1 CpGs. Combined filtering for dβ >0.2
and UTR/GB location (data not shown) yielded results
similar to those seen when we filtered for significant
methylation events and dβ >0.2 (Fig. 4b).
The relationship between methylation and gene
expression in fetal and adult liver
To explore the potential role of TSS/Ex1 methylation in
regulating gene expression, we examined the methylation
status of this region of genes that were overexpressed in
Fig. 2 Distribution of methylation data. Methylation sites were stratified based on the average methylation level. a A histogram showing the number of
CpGs at any given methylation level was generated using intervals of 0.05 for the range of 0 to 1. All methylation sites were included in the determination
of the mean of triplicate samples for each site. Fetal results are shown in blue and adult in red. b The difference in methylation between fetal and adult
data sets, calculated as the average delta beta for each site, is shown as a histogram. For this analysis, sites were included only if there was a q-significant
difference between fetal and adult
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fetal or adult liver as defined by a significant (q ≤ 0.05)
fold-difference of at least 5. For comparison purposes, we
expanded our analysis to include randomly selected genes
for which expression was similar in fetal and adult liver.
For this comparison group, we selected 4,631 genes repre-
sented on both the Affymetrix and the Illumina Infinium
arrays for which the fold-difference in expression between
fetal and adult liver was non-significant and less than 1.1.
A comparison of fetal and adult TSS/Ex1 methylation for
genes overexpressed in fetal liver showed what appeared
to be a fetal versus adult difference in methylation (Fig. 5a).
Fetal liver showed hypomethylation of these genes while
adult liver showed intermediate methylation and hyper-
methylation. However, these methylation patterns in both
fetal liver (Fig. 5b) and adult liver (Fig. 5c) were similar to
those seen for the control data set (genes with similar fetal
and adult expression).
In contrast, genes overexpressed in adult liver had TSS/
Ex1 methylation patterns in fetal and adult liver that not
only differed from one another (Fig. 6a), but also differed
from the equally expressed genes. TSS/Ex1 methylation in
fetal liver was high relative to the control data set (Fig. 6b).
In adult liver, methylation was low to intermediate
(Fig. 6c). Histograms based on the promoter-associated
regulatory feature group display similar patterns, but have
insufficient CpGs to be of statistical significance (data not
shown). Of note, there were very few unmethylated sites
in adult tissue from any of the three expression data sets.
We hypothesized that genes for which methylation
differed significantly between fetal and adult liver would
represent particular functional categories. To test this
hypothesis, we selected genes that were overexpressed in
fetal or adult liver as defined by a significant (q ≤ 0.05)
fold-difference of at least 5, and that showed a methyla-
tion difference (dβ >0.2, q ≤ 0.05) in the TSS/Ex1 region.
These 189 genes were entered into IPA. As a control
group to assess level of significance, we also analyzed
five equally sized sets of genes for which the fetal:adult
expression ratio was between −1.1 and 1.1. Results
(Table 1) show pathways involved in drug and xenobiotic
metabolism were significant. These pathways represent a
large subset of the categories found to be significant in
adult liver (Fig. 1b). They were largely accounted for by
genes encoding cytochrome p450 enzymes.
In addition to the previous analysis, we examined the
region-specific methylation data using a categorical ap-
proach. We defined hypomethylation, intermediate methy-
lation and hypermethylation as beta ranges from 0 to 0.3,
0.3 to 0.7 and 0.7 to 1.0, respectively. We again defined
location as TSS/Ex1 or UTR/GB. Genes were defined as
fetal overexpressed or adult overexpressed based on 5-fold
differences. Similarly expressed genes were defined as those
Fig. 3 Distribution of DNA methylation based on gene region. Triplicate fetal (blue) and adult (red) samples were analyzed using all CpGs that
were found to be methylated. The solid lines represent sites within 1,500 base pairs of the transcription start site or within the first exon, and the
dashed lines those sites that are within the gene body, 5’UTR or 3’UTR
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Fig. 5 Methylation of genes overexpressed in fetal liver. Overexpression was defined as a q-significant 5-fold difference in mean expression level
between fetal and adult. a Fetal (blue) and adult (red) TSS/Ex1 methylation (FDR q < 0.05 with dβ >0.2) results are shown juxtaposed against one
another. Also shown are methylation results for fetal (b) and adult (c) liver relative to data generated using randomly selected gene sets for which
fetal and adult liver expression was similar (fetal:adult ratio of −1.1 to +1.1; gray bars)
Fig. 4 The relationship between DNA methylation and gene expression. Results are shown as the average methylation for each gene (mean beta
value for the sites on that gene) versus the mean fetal:adult expression ratio for each gene. Data for the three fetal samples (blue) and the three adult
samples (red) were filtered using various parameters to generate the input for the analysis. a All genes for which methylation was significantly different
for fetal versus adult (q < 0.05). b Genes for which the fetal:adult difference in methylation (dβ) was at least 0.2. c Significant methylation; methylation
restricted to TSS/Ex1 CpGs. d Significant methylation; methylation restricted to TSS/Ex1 CpGs for which dβ was at least 0.2
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with a mean fetal:adult expression ratio of -1.1 to 1.1. The
Chi-Square test was used to assess statistical significance.
Results (Table 2) showed that both fetal overexpressed and
adult overexpressed genes differed significantly from simi-
larly expressed genes with regard to fetal and adult TSS/
Ex1 methylation. However, the fetal and adult methylation
patterns were similar. Therefore, we cannot assign bio-
logical significance to these differences. Fetal and adult
methylation of UTR/GB sites was similar comparing both
fetal and adult overexpressed genes with similarly expressed
genes. We interpreted this analysis as indicating that TSS/
Ex1 hypomethylation was more common for genes that
showed significantly different fetal versus adult expression
than for genes whose expression was similar in fetal and
adult liver. However, hypomethylation of these regions did
not correlate functionally with the changes in gene expres-
sion as fetal overexpressed genes show a similar level of up-
stream hypomethylation in both the fetus and adult.
To understand the utility of using DNA methylation
changes to predict gene expression, we calculated the
probability that a significant change in methylation of
any CpG would be associated with a difference in the
Figure 6 Methylation of genes overexpressed in adult liver. Overexpression was defined as a q-significant 5-fold difference in mean expression
level between fetal and adult. a Fetal (blue) and adult (red) TSS/Ex1 methylation (FDR q < 0.05 with dβ >0.2) results shown juxtaposed against one
another. Also shown are methylation results for fetal (b) and adult (c) liver relative to data generated using randomly selected gene sets for which
fetal and adult liver expression was similar (fetal:adult ratio of −1.1 to +1.1; gray bars)
Table 1 I PA categories, genes and p-values for Cannonical Pathways
Pathway Genes P-value








Bupropion Degradation CYP1A1,CYP1A2,CYP2E1,CYP2D6,CYP2C18,CYP2C9,CYP2A6,CYP2B6, CYP1B1,CYP2C8 5.92 × 10
−14
Acetone Degradation I (to
Methylglyoxal)
CYP1A1,CYP1A2,CYP2E1,CYP2D6,CYP2C18,CYP2C9,CYP2A6,CYP2B6, CYP1B1,CYP2C8 5.92 × 10
−14












PXR/RXR Activation CYP1A2,CES3,CYP2C9,CYP2A6,CYP2B6,SULT2A1,CYP2C8 7.87 × 10
−6
LPS/IL-1 Mediated Inhibition of RXR
Function
FMO3,SLC27A5,SLC10A1,ACSL4,CYP2C9,CYP2A6,CYP2B6,ABCC4, SULT2A1,CYP2C8 3.92 × 10
−5
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fetal:adult expression ratio (Table 3). CpGs that showed
hypermethylation in the fetal samples relative to adult
were associated with fetal underexpression of the associ-
ated genes. TSS/Ex1 CpGs with a fetal-to-adult methyla-
tion decrease of 0.5 or more was the best predictor;
33 % of these CpGs were associated with adult overex-
pression with a fold change of at least 2. TSS/Ex1 CpGs
with a fetal-to-adult methylation decrease of 0.2 or more
had a 20 % probability of association with 2-fold or
greater overexpression in the adult samples. UTR/GB
CpGs were about half as predictive as TSS/Ex1 CpGs. In
contrast, neither an increase in fetal to adult of dβ >0.2
nor even the more stringent dβ >0.5 was associated with
relative adult underexpression regardless of location
category.
To more thoroughly characterize the relationship be-
tween gene region-specific methylation and gene expres-
sion, we performed an analysis in which results were
separated based on CpG position within the various
gene regions – TSS200, TSS1500, 5’UTR, 1st exon, gene
body, or 3’UTR. The analysis was restricted to methyla-
tion events that differed significantly between fetal and
adult liver (FDR q < 0.05) with dβ >0.2. Results (Fig. 7)
showed a clear distinction between fetal overexpressed
and adult overexpressed genes. The former showed little
to no difference at any methylation site when compared
to equally expressed genes. In contrast, adult overex-
pressed genes showed hypermethylation in fetal liver
and intermediate methylation in adult liver relative to
equally expressed genes. Hypermethylation in fetal liver
Table 2 Percentage of CpG sites by location category and methylation level
Gene Expression Tissue Location on Gene Number of CpGs Hypomethylation (%) Intermediate Methylation (%) Hypermethylation (%)
Fetal Overexpressed Fetal TSS/Ex1 1640 76 10 14
UTR/GB 2312 31 11 58
Adult TSS/Ex1 1640 71 11 18
UTR/GB 2312 27 15 58
Adult Overexpressed Fetal TSS/Ex1 912 47 16 37
UTR/GB 957 24 16 61
Adult TSS/Ex1 912 56 24 20
UTR/GB 957 24 21 55
Similarly Expressed Fetal TSS/Ex1 2464 43 34 23
UTR/GB 4983 31 37 32
Adult TSS/Ex1 2464 16 60 23
UTR/GB 4983 12 57 30
CpGs were selected based on their relationship to genes whose expression differed significantly between fetal and adult liver (q < 0.05; fold-difference >5), or their
relationship to genes that were similarly expressed in the two groups (fold-difference ≤1.1). Based on criteria described in the text, CpGs were then categorized as
localized to within 200 or 1,500 base pairs of the transcription start site or the first exon (TSS/Ex1), or within the 5’UTR, 3’UTR or gene body, and as showing hypo-
, intermediate or hypermethylation
Table 3 Prediction Probability of DNA Methylation Change to Gene Expression Change
Gene expression induced in adult
Fetal Hypermethylation Location Number of CpGs >2-Fold >5-Fold
Fetal-to-Adult Decrease >0.2 TSS/Ex1 3,510 20 % 7 %
UTR/GB 8,807 12 % 2 %
Fetal-to-Adult Decrease >0.5 TSS/Ex1 391 33 % 11 %
UTR/GB 1,350 14 % 2 %
Gene Expression Induced in Fetus
Adult Hypermethylation Location Number of CpGs >2-Fold >5-Fold
Fetal-to-Adult Increase >0.2 TSS/Ex1 22,587 7 % 2 %
UTR/GB 54,769 5 % 2 %
Fetal-to-Adult Increase >0.5 TSS/Ex1 25,706 7 % 2 %
UTR/GB 62,226 5 % 2 %
CpGs were categorized based on fetal-to-adult differences in methylation status and their location within genes (TSS/Ex1 versus UTR/GB). Their predictive value
was assigned based on the fetal:adult difference in expression of the genes to which the respective CpGs were assigned
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Fig. 7 Distribution of gene region-specific methylation for genes overexpressed in fetal or adult liver. For all graphs, the density of fetal methylation is
shown in blue and adult in red. Solid lines represent the density plots for genes that are 5-fold overexpressed in fetal liver (left) or adult liver (right).
Results for genes that were equally expressed in fetal and adult liver (fetal:adult ratio of −1.1 to +1.1) are shown for comparison purposes as dotted
lines. Methylation data were filtered based on a significant (q < 0.05) difference of at least 0.2. The graphs are grouped in rows based on gene regions:
CpGs within 200 base pairs of the transcription start site (TSS200), within 1,500 base pairs of the transcription start site (TSS1500), or within the 5’UTR,
1st exon, gene body, or 3’UTR
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appeared to be consistent across both region categories.
Intermediate methylation exclusive of hypermethylation
in the adult was confined to the TSS locations.
Discussion
The goal of the present study was to characterize pat-
terns of DNA methylation in human fetal and adult liver
tissue so as to examine their relationship to patterns of
gene expression. We chose a direct comparison of liver
tissue from mid-gestation human fetuses and adult male
subjects for several reasons. While certainly not homo-
geneous, the majority of RNA and DNA from an adult
human liver sample is derived from hepatocytes, which
make up about 60 % of the cells and about 80 % of the
liver mass [26]. Although the fetal liver samples were
obtained from mid-gestation spontaneous miscarriages,
the expression and methylation results we obtained
showed minimal variance between samples. Variance
among adult samples was similarly low. We interpreted
this as indicating the absence of confounding secondary
effects of the tissue donors’ condition on our analyses.
Liver tissue contains a mix of cell types that may have
different patterns of DNA methylation, which can affect
the average liver tissue methylation patterns. In addition,
functional heterogeneity among individual cell types,
including hepatocytes [27], may contribute to cell-to-cell
variations in methylation. Fetal liver presents another
potential challenge in that it is a hematopoietic organ;
however, hematopoietic genes were not particularly
prominent among the genes detected in our expression
arrays.
Notwithstanding these potential limitations, we have
made several observations that are supported by mul-
tiple analyses. The first is that nearly half of the detected
methylation sites differed significantly between fetal and
adult liver. With regard to the relationship between
methylation and gene expression, our data indicate that
there may be fundamentally different regulatory roles in
fetal and adult liver. Genes that were overexpressed in
the fetus did not differ in their methylation pattern from
genes that showed similar expression levels in the fetal
and adult samples. In contrast, genes that were overex-
pressed in the adult showed the expected inverse rela-
tionship to methylation. This was especially apparent
among the sites upstream from the TSS or within the
first exon and that showed relatively greater differences
in methylation between the fetal and adult samples.
Although our study looked at only two points in time,
our findings are consistent with so-called “epigenetic
drift” in which DNA methylation patterns diverge over
time, either through stochastic changes in methylation
or through responses to differing environmental condi-
tions [28–30]. We found that fetal versus adult differ-
ences in methylation tended to be small; about 80 % of
significantly different sites differed in methylation to
only a small degree in absolute terms (≤0.2). Changes in
these sites are consistent with the aforementioned “epi-
genetic drift” where shifts in methylation affect only a
random subset of cells. Since DNA methylation values
for a single site on a single chromosome are either 0 or
1, and given that DNA methylation is stochastic, values
less than 0.1 indicate that no more than 10 % of the cell
population have acquired a methyl group at a given CpG
location. Nonetheless, our data show the expected
asymmetry in methylation changes with age, indicating a
propensity to accumulate DNA methylation with the
transition from fetal life to adulthood.
A high proportion of DNA methylation changes, even
those in gene regions expected to exert an effect on
transcription, were unassociated with changes in gene
expression. The methylation pattern in fetal liver was
consistent with a relationship between hypomethylation
and increased gene expression. However, the fetal
methylation pattern for these fetal overexpressed genes
was similar to the pattern for genes expressed at similar
levels in fetus and adult. In contrast, genes overex-
pressed in the adult tissue showed patterns that differed
from those seen for similarly expressed genes. Hyperme-
thylation in the fetus was associated with overexpression
in the adult. However, very few genes were hypomethy-
lated in the adult. Rather, there appeared to be a rela-
tionship between higher gene expression in the adult
and intermediate adult methylation. This is consistent
with the conclusions of Bestor et al. [31] who posited
that the accumulation of DNA methylation later in life
may not be a regulator of gene expression.
This is in contrast to hypermethylation in fetal liver.
The highly methylated CpGs in fetal liver may represent
a set of actively methylated sites that are independent of
X-inactivation or transposon silencing. Given the rela-
tionship between fetal hypermethylation of TSS/Ex1
CpGs and higher gene expression in the adult, we specu-
late that these sites may contribute to the induction of
genes associated with functional differentiation in the
adult. This is supported by the preponderance of genes
encoding cytochrome P450 enzymes among those that
underwent a reduction in methylation from fetus to
adult. Such a relationship would be similar to that re-
ported by Kacevska et al. for CYPA4 [32]. These authors
found hypermethylation of key upstream regulatory sites
in this gene in fetal relative to adult human liver.
As in our own analyses, Bonder et al. [33] analyzed the
transcriptomes and DNA methylomes of human fetal and
adult liver. Fetal samples were acquired at gestational
week 8–12, a substantial difference from our own study.
In general, these authors’ findings were consistent with
many of our observations. Methylation within promoter
regions tended to be associated with negative regulation
Huse et al. BMC Genomics  (2015) 16:981 Page 10 of 14
with gene expression, as opposed to methylation within
gene bodies. The authors attributed this to the ability of
methylation to inhibit transcription initiation but not
transcription elongation [22]. In contrast to our results,
these authors found that only 8 % of CpGs showed a sig-
nificant difference in beta of >0.2 comparing the fetal and
adult samples. This may have related to the gestational
age span of the fetal samples. However, like our analyses,
they found a slight hypomethylation preponderance of
CpGs in fetal liver. Consistent with our findings, they saw
that CpGs hypomethylated in fetal liver were enriched
among genes encoding components of steroid and lipid
metabolic pathways.
An additional focus of our analyses was the relation-
ship between localization of methylation within distinct
gene regions and effects on gene expression. It has been
noted previously that methylation within promoter re-
gions is low relative to the higher rates seen within the
gene body, the latter being primarily within exons [5].
Brenet et al. [25], studying human cell lines, noted that
methylation within a gene’s first exon is more tightly
linked to silencing of transcription than is methylation
upstream of the transcription start site. Filtering of our
methylation data for location and a significant fetal-to-
adult reduction in methylation at specific sites was most
effective in identifying candidate regulatory methylation
sites. However, even those sites identified by the most
stringent predictor (a significant fetal-to-adult decrease
of at least 0.5 in a TSS/Ex1 site) were unassociated with
significant changes in gene expression two thirds of the
time. Furthermore, promoter regions and exon 1 sites
were not distinguishable from one another in their rela-
tionship to gene expression. It is evident from our data
that epigenetic control of gene expression via DNA
methylation is not only extremely complex, but that the
nature of its relationship to gene expression is, as yet, un-
predictable. Our data indicate that in human liver tissue a
large percentage of statistically significant changes in
DNA methylation are unrelated to the regulation of gene
expression during the transition from fetal to adult life.
Multiple regulatory mechanisms are likely to account for
the regulation of gene expression during liver development.
Regulation of gene expression is exceedingly complex and
involves the interplay between chromatin structure and
expression and activity of transcription factors. Specific
histone modifications are present in the mouse endoderm
and have been linked to lineage specification of liver and
pancreas [34]. Dynamic changes in histone posttransla-
tional modifications are also involved in the developmental
regulation of Cyp3a genes in mouse liver [35]. Several stud-
ies have also shown changes in the profile of miRNAs
during liver development with a subset being specifically
expressed in fetal liver suggesting an important role in the
regulation of gene expression [36–38].
However, we also identified a subset of genes that are
targeted for DNA methylation during fetal development
when the expression of these genes is down-regulated.
The expression of these genes in adulthood correlates with
intermediate methylation. This is consistent with the
demethylation of one copy of the gene during active gene
transcription. It remains to be determined if these genes
represent reversible gene silencing and, if they do not,
why these upstream CpGs are targeted for methylation
during fetal development when upstream CpGs are prefer-
entially unmethylated in fetal tissue. Finally, our data indi-
cate that methylation, within promoter regions or first
exons in particular, has a regulatory influence on genes
that are overexpressed in adult relative to fetal liver. The
converse was not the case; a transition from hypomethyla-
tion in the fetus to hypermethylation in the adult was not
associated with altered gene expression. These results
indicate a fundamentally different role for methylation in
the regulation of genes that are inhibited versus induced
during the transition from fetal to adult life.
Our results indicate that in a physiological setting
there exists a relationship between DNA methylation
and gene expression among genes that are induced be-
yond mid-gestation. The corollary relationship between
genes overexpressed in the fetus and increased methyla-
tion in the adult is not similarly supported by our data.
We therefore conclude that there is a fundamentally
different relationship between DNA methylation and
gene expression among genes that are hypermethylated
in the fetus versus those that contribute to the trend to-
ward increasing methylation in the adult.
Conclusions
Nearly half of the CpGs in human liver show a significant
difference in methylation comparing mid-gestation fetal
and adult samples. While most methylation events are not
associated with altered gene expression, sites within pro-
moter regions or first exons that show a transition from
hypermethylation in the fetus to hypomethylation or inter-
mediate methylation in the adult are associated with in-
verse changes in gene expression. In contrast, increases in
methylation going from fetal to adult appear to neither
regulate nor reflect fetal-to-adult decreases in expression.
These findings indicate fundamentally different roles for
and/or regulation of DNA methylation in human fetal and
adult liver.
Methods
Liver tissue procurement and processing
Human fetal liver was obtained from spontaneous male
fetal stillbirths, gestational weeks 20–22, delivered at
Women and Infants Hospital (Providence, RI). Macerated
fetuses, presumed to have a long period between fetal
demise and delivery, and fetuses with visible congenital
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abnormalities or those delivered by elective or medical
abortion were excluded. Details of fetal examination were
described by De Paepe et al. [39]. Once obtained, the fetal
liver was split and a portion of the liver immediately flash
frozen in liquid nitrogen and stored at −80 °C until use.
The other portion was fixed in formalin and processed for
hematoxylin and eosin staining. The tissue procurement
protocol was approved by the Women and Infants Institu-
tional Review Board and fully informed written parental
consent was obtained according to the approved protocol.
Snap frozen, normal adult human liver from males aged
55–62 years was obtained through the Liver Tissue Cell
Distribution System (Pittsburgh, PA), which is funded by
NIH Contract # HHSN276201200017C. Specimens were
stored at −80 °C until use.
Gene expression analysis
DNA and RNA were isolated from triplicate human fetal
and adult livers using the AllPrep DNA/RNA mini Kit
(Qiagen, Redwood City, CA). RNA quality was assessed
using the Agilent 2100 Bioanalyzer (Santa Clara, CA).
RNA was of high quality with all samples giving a RNA
integrity number (RIN) between 9.5 to 9.7. RNA was
analyzed using Affymetrix Genechip Human Gene ST
1.0 arrays (Affymetrix, Santa Clara CA) by Brown
University’s Genomics Core.
The Affymetrix CEL files were imported into R and
normalized using the RMA algorithm and then each
transcript was associated with standard gene symbols
(packages oligo [http://www.ncbi.nlm.nih.gov/pubmed/
20688976] and hugene10sttranscriptcluster.db [40]).
Gene expression and statistical significance of differ-
ences between fetal and adult samples were calculated
using the limma package [41]. Microarrays were ana-
lyzed using Gene Set Enrichment Analysis to identify
functional gene sets that were enriched in experimental
groups for the full spectrum of genes detected in the array
[21]. For Ingenuity Pathway Analysis (IPA®; Qiagen,
www.qiagen.com/ingenuity), genes whose expression dif-
fered significantly (FDR q < 0.05) between the fetal and
adult groups by >5-fold were compared to 5 equally sized
groups of control genes that were randomly selected from
the list of genes that showed a fold-change <1.1 [42]. IPA
results were considered significant when the p-values were
below the lowest p-value for the 5 control gene sets.
DNA methylation analysis
DNA quality was assessed using a Nanodrop ND
1000 (Thermo Scientific, Wilmington, DE) and gel
electrophoresis. All samples contained high molecular
weight genomic DNA with 260/280 greater than 1.8
and 260/230 greater than 1. DNA (3 μg) was sent to
the W.M. Keck Biotechnology Resource Laboratory at
Yale University for methylation profiling using the
Illumina Infinium® HumanMethylation450 BeadChip
(Illumina, San Diego, CA). This array includes over
489,000 methylation sites across the entire human
genome. The chip was designed to cover 99 % of
RefSeq genes and different locations within the pro-
moter region, 5’ and 3’ UTRs, and the body of the
gene. The gene body sites explicitly include the first
exon. Samples were processed for hybridization ac-
cording to the manufacturer’s instructions.
Raw DNA methylation array data files were imported
into the R statistical package [43]. The probesets were
quality filtered for adjusted detection p-values <0.05,
batch corrected with functional normalization [44], and
then normalized across the two probe types using beta
mixture quantile normalization (BMIQ) [45], all imple-
mented in the watermelon package [46]. Our final pro-
beset included 482,757 methylation sites along the
genome. We then linked the UCSC Genome Browser
annotation (version hg19 of the human reference gen-
ome, http://genome.ucsc.edu) to each of the CpG sites
on the array [47]. Based on the UCSC chromosome
annotation, we filtered out DNA methylation from the X
and Y chromosomes. The resulting methylation values
follow a beta distribution ranging from 0 if potential
sites in the sample are unmethylated at a locus to 1 if all
are methylated. Beta values between 0 and 1 reflect the
proportion sites methylated at a given locus. Fetal:adult
differences are referred to as delta beta values.
We used surrogate variable analysis [48] to remove pos-
sible confounding latent variables associated with donor
characteristics followed by linear modeling and empirical
Bayes moderation [49] and a Benjamini-Hochberg false
discovery rate correction [50] on the logit-transformed beta
methylation values of the adult versus fetal samples [48].
Availability of supporting data
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